Prediction of HIV mortality in Thailand using three data sets from the national AIDS program database by Hiwot D. Tulu, et al.
Sains Malaysiana 49(1)(2020): 155-160
http://dx.doi.org/10.17576/jsm-2020-4901-19
Prediction of HIV Mortality in Thailand using Three Data Sets from the National 
AIDS Program Database
(Anggaran Kematian HIV di Thailand menggunakan Tiga Set Data daripada Pangkalan Data Program AIDS 
Kebangsaan)
Hiwot D. Tulu*, Apiradee Lim, Arinda Ma-a-Lee, Kanitta Bundhamcharoen, & Nuttapat Makka
ABSTRACT
HIV continues to hinder the growth and development of a country and identifying the mortality rate will help to address 
this problem. Therefore, we sought to examine HIV mortality in Thailand in the years 2014 and 2015. A retrospective 
study was conducted to investigate HIV mortality in all regions of Thailand. For the reliability of this study, the data were 
drawn from two main sources, Bureau of Registration and Administration (BORA) and the National Health Security 
Office (NHSO) of Thailand. A total of 23,243 deaths were recorded in years 2014 and 2015. Negative binomial regression 
was used to predict and compare HIV mortality rates by year, age group and gender. The overall HIV mortality accounted 
for 2.6% of all reported deaths, representing 18.3 deaths per 100,000 populations. Among HIV deaths, 91% of them 
participated in the National AIDS Program (NAP) and 56% of them received Antiretroviral Therapy (ART). There was 
statistically significant effect, with males having a higher death rates than females. Despite the relevance of reduction 
of HIV mortality in Thailand, our study clearly shows that HIV mortality in Thailand is much dependent on age and 
gender. Thus, we suggest continued effort is needed to address gender and age difference.
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ABSTRAK
HIV terus menghalang pertumbuhan dan perkembangan negara dan mengenal pasti kadar kematian akan membantu 
menangani masalah ini. Oleh itu, kami berusaha meneliti kadar kematian akibat HIV di Thailand pada tahun 2014 dan 
2015. Kajian retrospektif telah dijalankan untuk mengkaji kadar kematian HIV di semua rantau di Thailand. Untuk 
kebolehpercayaan kajian ini, data tersebut diambil daripada dua sumber utama, Biro Pendaftaran dan Pentadbiran 
(BORA) serta Pejabat Keselamatan Kesihatan Kebangsaan (NHSO) Thailand. Sebanyak 23,243 kematian dicatatkan 
pada tahun 2014 dan 2015. Regresi binomial negatif digunakan untuk meramalkan dan membandingkan kadar kematian 
HIV mengikut tahun, kumpulan umur dan jantina. Keseluruhan kematian HIV menyumbang 2.6% daripada semua 
kematian yang dilaporkan, mewakili 18.3 kematian bagi setiap 100,000 penduduk. Antara kematian akibat HIV, 91% 
daripadanya telah menyertai Program AIDS Kebangsaan (NAP) dan 56% daripadanya menerima Terapi Antiretroviral 
(ART). Terdapat kesan yang signifikan secara statistik, dengan lelaki mempunyai kadar kematian lebih tinggi berbanding 
wanita. Walaupun terdapat relevan pengurangan kematian HIV di Thailand, kajian kami dengan jelas menunjukkan 
bahawa kematian HIV di Thailand sangat bergantung kepada umur dan jantina. Oleh itu, kami mencadangkan usaha 
berterusan diperlukan untuk menangani perbezaan jantina.
Kata kunci: Binomial Negatif; kematian HIV; Program AIDS Kebangsaan; ramalan
Introduction
It is widely viewed that mortality negatively affects the 
development of a country and causes a burden to its health 
program. According to the World Health Organization, 
56.9 million deaths were recorded worldwide in 2016 
(WHO 2018). Human Immunodeficiency Virus (HIV) has 
been a major cause of death, particularly in developing 
countries since the first epidemic broke out in the USA in 
the 1980s (CDC 2001). The prevalence of HIV mortality 
was ranked as the 39th cause of death in 1995 and 11th in 
2015 (Wang et al. 2016). While in recent years, the burden 
caused by the disease is decreasing, it remains an important 
area of study.
Since the outbreak of the epidemic, more than 70 
million people have been infected and about 35 million 
people have died from HIV/AIDS (Lima 2015; UNAIDS 
2016). Asia is the second largest region next to sub-Sahara 
Africa. Between years 2005 and 2012, HIV mortality in 
Asia dropped from 2.3 million to 1.6 million (Ishikawa et 
al. 2016; Zayeri 2016). The HIV mortality decreased from 
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1.8 million in year 2005 to 1.2 million in 2015 (Wang et 
al. 2016).
Thailand had the highest HIV prevalence in Southeast 
Asia in 2014. In year 2016, there were approximately 
450,000 people living with HIV; with 6,400 new cases and 
16,000 deaths related to HIV/AIDS (Chaivooth et al. 2017). 
Among Asian countries, Thailand was the first country to 
propose Antiretroviral Therapy (ART). In year 2000, the 
National Health Security Office (NHSO) initiated a free 
trial program called National Access to Antiretroviral 
Therapy Program (NAPHA). Due to the increase of ART 
coverage in Thailand, HIV mortality was reduced from 
16% in 2008 to 3% in 2014; for those who started ART 
(Chasombat et al. 2009, 2006).
Although several studies have been conducted to 
recently assess HIV mortality in Thailand, most of these 
studies are sourced from a single database (Fregonese et 
al. 2012; Jongsthapongpanth et al. 2010; Quan et al. 2007). 
There is a lack of reliable statistics from the vital 
registration system for determining the cause-of-death in 
Thailand (Porapakkham et al. 2010). Data from a single 
source could not provide sufficient and reliable information 
(Vapattanawong & Prasartkul 2011). Therefore, it is 
essential to use a linked database in order to obtain most 
accurate outcome. Our study linked three data sources 
obtained from the Bureau of Registration and Administration 
(BORA) and the National Health Security Office of 
Thailand.
This study aimed to investigate HIV mortality in 
Thailand between 2014 and 2015 by age group and gender. 
Such information assists policy makers to examine the 
burden of disease and to provide information for the Joint 
United Nations Programme on HIV/AIDS (UNAIDS) to meet 
the goal of reducing HIV related death. 
Materials and Methods
data sources and management
A retrospective study was conducted to predict HIV 
mortality for years 2014 and 2015. Data were collected 
from the National AIDS Program (NAP), the Bureau of 
Registration and Administration (BORA) and the National 
Health Security Office (NHSO) of Thailand. The data 
sources were from vital registry inpatient registration and 
antiretroviral therapy registration. Deaths diagnosed as HIV 
was obtained from vital registry (VR), were linked to the 
NAP and inpatient (IP) database. NHSO used individual 
unique identification numbers consisting of 13 characters 
to avoid overlapping while linking the three datasets 
together (Naiwatanakul et al. 2016). The Antiretroviral 
therapy registration data set consist of HIV patient history 
following ART therapy in each hospital and health facilities 
across Thailand obtained by NAP. As Thai law requires 
death to be reported within 24 h, an electronic database 
was created in 2008 to link death registry with the NHSO 
of Thailand enabling health professionals to complete 
online forms for each visit. In addition, this program 
provides free ART treatment according to national 
guidelines for every HIV/AIDS infected Thai patients across 
regions in Thailand (Chaivooth et al. 2017).
A total number of 881,598 deaths were recorded for 
the years 2014 to 2015 with 435,634 deaths in 2014 and 
445,964 deaths in 2015. Of these, 23,243 deaths (2.6%) 
were recorded from HIV/AIDS, which were confirmed by 
the International Classification of Disease Version 10 (ICD-
10) in NAP database. Population data for the study period 
from the Ministry of Public Health (MOPH) were used as 
denominators.
Information from the data included age, gender (male/
female), year of death (2014/2015), receipt of ART (yes/
no), NAP participation (yes/no), place of death (inside/
outside hospital) and number of HIV deaths. Age was 
categorized into eight age groups as follows: 0-29, 30-34, 
35-39, 40-44, 45-49, 50-54, 55-59 and 60+. 
statistical analysis
Descriptive analysis was performed to describe the 
distribution for each variable. HIV mortality rates were 
calculated per 100,000 population separated by age, gender 
and year of death. To manage the interaction effect between 
age group and gender, we combined these two variables 
together to form a new variable called gender-age group 
with 16 categories (8 age groups × 2 gender groups). For 
statistical modeling, explanatory variables selected for the 
study were gender-age group and year, with the HIV 
mortality rate as outcome. Poisson regression was first 
fitted. However, it assumes that the mean value equals the 
variance. This assumption was not supported by the data, 
as a negative binomial model was used to accommodate 
over-dispersion (Jansakul & Hinde 2004; Lima et al. 2015). 
Sum contrast was used to conduct and plot confidence 
intervals (Tongkumchum & McNeil 2009). Data 
management, statistical analysis, and graphical displays 
were carried out using the R program (R Core Team 2016).
This study has been reviewed by Human Research 
Ethics in full compliance with the Declaration of Helsinki 
and the Belmont Report by Prince of Songkla University, 
Pattani Campus committee.
Results and Discussion
There were 11,767 and 11,476 deaths due to HIV/AIDS in 
2014 and 2015 accounted for 2.7% and 2.6% of all reported 
deaths. The results obtained from the descriptive analysis 
of HIV mortality are summarized in Table 1. Males 
accounted for 65% of deaths. The highest HIV mortality 
(19%) was recorded in age group 40 to 44, followed by 
ages 45-49 (17.8%), 35-39 (14.5%), and 50-54 (12.6%), 
60+ years (9.9%), 0-29 (9.1%), and 30-34 years (8.9%), 
respectively.  The lowest death rate was found in age group 
55-59 (7.9%). Of all HIV deaths, 55.8% were on ART 
treatment and 61.6% of deaths occurred inside hospital. In 
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addition, from all HIV deaths 91.2% of them were included 
in the National AIDS program (NAP). Numbers of HIV 
deaths in both years were similar.
HIV/AIDS mortality rates per 100,000 populations 
were calculated by gender-age group and year as shown 
in Table 2. The highest mortality rate was found in age 
group 40-49 years in males and age group 40-44 years in 
females. HIV/AIDS mortality rates in year 2014 and 2015 
were 18.6 and 18.1 per 100,000 populations. 
The results from the statistical analysis for Poisson 
and negative binomial models are presented in Figures 1 
and 2. 
Figure 1 shows plots of residuals after fitting models 
for HIV mortality data with each regression model. In the 
Poisson model, the deviance is 77.6 on 15 degrees of 
freedom with a p-value of <0.001. The highly significant 
p-value shows that the Poisson model fails to fit the data 
due to over dispersion. The deviance residual plot for the 
negative binomial model, over dispersion parameter gives 
the deviance 15.4 degree of freedom which is an acceptable 
fit for the model with p-value 0.42. 
The coefficients and standard errors of each variable 
obtained from negative binomial model were converted 
into death rates and their confidence intervals. Then, 95% 
confidence interval (CI) plot was created as shown in Figure 
2. The horizontal line defines the overall mean of the death 
rate. The dots aside with the upper and lower bounds based 
on the CI indicates the death rate. The CI above or below 
the horizontal line represents groups that are greater than 
or lower than the overall mean. However, if the CI crossed 
the horizontal line indicates that there is no evidence 
corresponding group differs from the mean value. 
Statistically, the difference between genders was significant, 
with males having a higher HIV death rate than females. 
Males aged 40-49 years had the highest death rate when 
compared with the other age groups. The highest death rate 
among females was found in age group 40-44 years. Both 
males and females had the lowest death rate in age group 
0-29 years. Death rates between year 2014 and 2015 were 
not statistically significant different.
hiv/aids mortality rate in thailand
Overall, HIV mortality in both years was 2.6%, representing 
18.3 deaths per 100,000 populations. Mortality rates in 
Thailand fell after the introduction of ART in 1997 but had 
TABLE 1. Characteristics, NAP participation and receipt of 
ART of HIV mortalities
Variables Number %
Gender
Male 15,126 65.0
Female 8,117 35.0
Age groups (Years)
0-29 2,118 9.1
30-34 2,076 8.9
35-39 3,393 14.5
40-44 4,417 19.0
45-49 4,140 17.8
50-54 2,937 12.6
55-59 1,841 7.9
60+ 2,321 9.9
NAP participation
Yes 21,207 91.2
No 2,036 8.8
Receipt of ART 
Yes 12,958 55.8
No 10,285 44.2
Place of death 
Inside hospital 14,280 61.6
Outside hospital 8,903 38.4
Year
2014 11,767 50.6
2015 11,476 49.4
TABLE 2. HIV mortality rates per 100,000 population by 
gender-age group and year
Variables Number of deaths Mortality rate per 100,000 
Male
0-29 1,281 5.1
30-34 1,356 27.1
35-39 2,117 40.8
40-44 2,871  55.6
45-49 2,783 55.6
50-54 1,980 43.8
55-59 1,233 34.3
60+ 1,505 18.3
Female
0-29 837 3.4
30-34 720 14.5
35-39 1,276 24.3
40-44 1,546 28.6
45-49 1,357 25.1
50-54 957 19.3
55-59 608 15.0
60+ 816 7.9
Year
2014 11,767 18.6
2015 11,476 18.1
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been continued stable later 2006, and mortality had 
decreased from 16% to 3% in 2014 in 2008 for patients on 
ART treatment (Chaivooth et al. 2017; Judd et al. 2018). 
Essentially the declining mortality was evident from 2003 
to 2006 that indicated the starting point of universal ART. 
In addition, this reduction could be due to the institution 
of the NAP in 2008 to freely enroll all HIV patients on ART 
(Bundhamcharoen et al. 2011; Chaivooth et al. 2017; 
Naiwatanakul et al. 2016). In our study, 91% of HIV deaths 
enrolled in the NAP and 56% of HIV deaths received ART. 
Among 21,207 HIV deaths participated in NAP, 12,958 
deaths received ART accounted for 61%. The left 39% of 
deaths did not receive ART were in high percentage. It can 
be indicated that if more patients enrolled on ART, the 
mortality rate would have been lower than reported. Apart 
from the NAP, the Thai government has also undertaken 
different responsive measures to the HIV pandemic and 
this measure have also caused such reduction in mortality 
rates (Siraprapasir et al. 2016).
HIV mortality in Thailand is significantly associated 
with gender-age group. HIV mortality was higher in males 
across all age groups compared to females and the mortality 
rate was also higher than the overall mean mortality rate. 
There was a total HIV death of 15,126 for males over the 
period and this figure represents a reduction from 26,400 
death reported in 2004. The number of deaths in females 
FIGURE 1. Residual plot of Poisson regression model (a), negative binomial model (b)
FIGURE 2. 95% CI plot for HIV mortality rates from negative binomial model
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also reduced from 11,000 in 2004 to 8,117 in 2015 
(Siraprapasir et al. 2016). Similar findings have been 
documented in Italy, Thailand and various parts of the 
world to confirm that higher HIV deaths are recorded in 
males (Aldaz et al.  2011; Alibhai et al.  2010; 
Bundhamcharoen et al. 2011; Gonzalez et al. 2011). 
Globally, the variation between the mortality rates of males 
and females could be attributed to different factors such as 
the fact that females are likely to enroll in antiretroviral 
programs early, especially during pregnancy (Chen et al. 
2008). Also, the prevention of Mother-to-Child 
Transmission (PMTCT) programs gives women access to 
antiretroviral therapy faster than males and men have poor 
adherence to treatment than females (Johannessen et al. 
2008; Seyoum et al. 2017).
Although there is evidence to show that age was not 
significantly associated with HIV mortality (Alibhai et al. 
2010; Antiretroviral Therapy Cohort Collaboration 2010; 
Lieb et al. 2002), our study found otherwise. Results from 
the present study suggest that HIV mortality in Thailand is 
much dependent on age. The highest death rate was found 
among males aged 40-49 years and females aged 40-44 
years. Our finding indicated that HIV deaths occurred in 
older age than global deaths reported by Frank et al. (2019) 
which showed that the highest HIV death rate in year 2017 
was found in females aged 30-34 years and in males aged 
35-39 years. One unanticipated finding in this study was 
that no deaths were recorded from HIV for those aged below 
two years. In our study we used three data base settings 
for the confirmation of the cause of death (COD). It appears 
that NAP is successful in preventing mother to child 
transmission (PMTCT). After a report, in 2016 when 
Thailand became the first country in Asia to eliminate 
mother to child transmission reduces maternal and infant 
morbidity and mortality due to Antenatal Care (ANC) 
(Ishikawa et al. 2016).
Conclusion
Despite the relevance of reduction of HIV mortality in 
Thailand, this study clearly illustrates that HIV mortality 
rate is dependent on age and gender in Thailand. The study 
of our result affirmed that 61% percent of the NAP patients 
were under ART to prevent the growth of HIV virus. There 
was a statistical significance in HIV mortality rate where 
male have higher than females. Males aged 40-49 years 
and females aged 40-44 years had the highest mortality 
rate. Therefore, regardless of the pertinence of reduction 
in the HIV mortality rate in Thailand, the study presented 
that HIV mortality in Thailand is much dependent on age 
and gender. Thus, we suggest continued effort is needed 
to address gender and age difference.
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